Related Experiment Video
Updated: Apr 26, 2026
04:56
Author Spotlight: Advancements in Understanding and Combatting Shigella Infections
Published on: February 9, 2024
1.9K
Shigella: A Highly Virulent and Elusive Pathogen
Mussaret Bano Zaidi1, Teresa Estrada-García2
1Microbiology Research Laboratory, Hospital General O'Horan, Av. Itzaes x Jacinto Canek, C.P. 97000 Mérida, Mexico. Phone and fax: +52-(999) 923-8673, mbzaidi@prodigy.net.mx ; Infectious Diseases Research Unit, Hospital Regional de Alta Especialidad de la Península de Yucatán, Km. 8.5 Carr. Merida-Cholul S/N, Col. Maya, C.P. 97134, Merida, Mexico.
Current Tropical Medicine Reports
|August 12, 2014
Summary
Shigellosis remains a global health challenge, especially in Asia and Africa, due to multidrug-resistant strains. An effective vaccine is urgently needed to combat this virulent pathogen and reduce disease burden.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Background:
- Shigellosis, caused by the bacterium Shigella, presents a significant global health burden, particularly in resource-limited regions of Asia and Africa.
- While mortality has decreased, Shigella infections range from mild diarrhea to severe dysentery with potentially fatal complications like hemolytic uremic syndrome.
- Shiga toxin-producing Shigella dysenteriae subtype 1 is associated with the most severe disease and highest mortality rates.
Purpose of the Study:
- To highlight the persistent global impact of shigellosis.
- To underscore the challenges posed by multidrug-resistant Shigella strains.
- To emphasize the urgent need for an effective Shigella vaccine.
Main Methods:
- Literature review of Shigella epidemiology and clinical manifestations.
- Analysis of antibiotic resistance trends in Shigella.
- Assessment of current management strategies and prevention gaps.
Main Results:
- Shigellosis remains prevalent, with Shigella dysenteriae and Shigella flexneri dominating in resource-limited settings.
- Emergence of multidrug-resistant strains renders common antibiotics ineffective, complicating treatment.
- Existing treatments are challenged by widespread antibiotic resistance.
Conclusions:
- Shigellosis continues to be a major public health concern requiring innovative control strategies.
- The rise of antibiotic resistance necessitates alternative approaches to managing and preventing shigellosis.
- Development of a Shigella vaccine is critical for reducing the global disease burden.
Related Concept Videos
01:18Bacterial Gastroenteritis
83
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid...
83
01:25Cholera
140
Cholera is an acute gastrointestinal disease caused by the Gram-negative bacterium Vibrio cholerae. It is transmitted primarily via the fecal-oral route through the ingestion of contaminated water or food.Vibrio cholerae is a motile, Gram-negative bacterium of the family Vibrionaceae, primarily associated with waterborne outbreaks in areas with inadequate sanitation. Although over 200 serogroups of V. cholerae exist, only O1 and O139 are responsible for epidemic cholera. The O1 serogroup,...
140
01:30Reservoir of Infection
80
Infectious diseases arise from intricate interactions between pathogens and their reservoirs. A reservoir of infection refers to the natural habitat where a pathogen lives, grows, and multiplies, serving as a continual source of infection. Reservoirs are broadly classified as either living or nonliving, and each plays a unique role in disease transmission, significantly influencing public health interventions and control strategies.Humans act as reservoirs for a wide array of pathogens,...
80
01:15Diversity of Protists I
2.3K
Excavata is a diverse group of protists that includes both chemoorganotrophic and phototrophic species, with some thriving in anaerobic environments. Among the key groups within Excavata are diplomonads and parabasalids, which are flagellated protists that lack mitochondria and chloroplasts. These microorganisms typically inhabit anoxic environments, such as the intestines of animals, where they exist either symbiotically or as parasites, relying on fermentation for energy production. Some...
2.3K
01:29Bacterial Phylum Chlamydiae
832
The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic...
832
01:28Fungal Phylum Microsporidia
775
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
775